Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other ho... Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 7.57575757576 | 0.33 | 0.385 | 0.3009 | 421576 | 0.35588359 | CS |
4 | 0.0053 | 1.51558478696 | 0.3497 | 0.385 | 0.2542 | 533040 | 0.32081909 | CS |
12 | -0.1285 | -26.5770423992 | 0.4835 | 0.525 | 0.2542 | 468432 | 0.34709189 | CS |
26 | -1.275 | -78.2208588957 | 1.63 | 2.52 | 0.2542 | 564128 | 0.9151567 | CS |
52 | -4.255 | -92.2993492408 | 4.61 | 7.74 | 0.2542 | 332222 | 1.08400438 | CS |
156 | -29.321 | -98.8037471357 | 29.676 | 35.664 | 0.2542 | 410408 | 15.61520275 | CS |
260 | -32.645 | -98.9242424242 | 33 | 127.2 | 0.2542 | 3034952 | 49.29049244 | CS |
Symbole | Prix | Vol. |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 28,481 (0,00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | US$ 37,78 (0,00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 26,4967 (0,00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | US$ 26,275 (0,00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | US$ 25,11 (0,00%) | 0 |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales